Other

NR566 Week 2 Study Outline_ Chapter 17: Drugs Affecting the Respiratory System

9 views 0 purchase

Course
AIT Nursing (NR566)

Institution
Thompson River University (TRU )

[Show more]

Preview 4 out of 34 pages

View example

Uploaded on February 10, 2021
Number of pages 34
Written in 2020/2021
Type Other
Person Unknown

chapter 17 drugs affecting the respiratory system
nr566 week 2 study outline chapter 17 drugs affecting the respiratory system
nr566 week 2 study outline
bronchodilators
bronchodilators beta 2 re

Welch1 Member since 6 year 61 documents sold

CA$18.57

Added

Add to cart Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

NR566 Week 2 Study Outline
Chapter 17: Drugs Affecting the Respiratory System
Bronchodilators:
Beta 2 Receptor Agonists (B2RA): Short and long acting beta agonists
• B2RA widely used in all ages to treat reversible bronchoconstriction caused by reactive airway disease
(RAD) or COPD
• Bronchodilators
• Short-acting beta agonists: Albuterol (ProAir, Ventolin, Proventil) , metaproterenol
(Alupent), terbutaline (Brethine, Brethaire), bitolterol (Tornalate), pirbuterol (Maxair), and levalbuterol
(Xopenex)
• Long-acting beta agonists: arformoterol (Brovana), salmeterol (Serevent), formoterol (Foradil), and
indacaterol (Arcapta Neohaler)
• Drug of choice during pregnancy for asthma

Pharmacodynamics
• Act on smooth muscle to reverse bronchospasm, decreases airway resistance and residual volume and
increasing VC and airflow
• Stimulate beta 2 adrenergic receptors in the lungs to increase cAMP production which relaxes bronchial
smooth muscle and inhibits mediators from hypersensitivity cells (mast cells)
• All beta agonists stimulate beta 1 activity (increased HR, tremor)f

Short Acting Beta Agonists
• Albuterol
o Selective beta2 agonist with minor beta1 activity
o Often first-line drug r/t less ADRs than the other drugs in this class
o Increases HR by stimulating beta 2 receptors in the heart and vascular smooth muscle
• Levalbuterol: (similar to albuterol), where the (S)-isomer from racemic albuterol is removed
• Pirbuterol: selective beta 2 agonist, similar to albuterol
• Terbutaline: similar to albuterol, selective beta 2 with minor beta 1 activity
o Known to inhibit uterine contractions
• Metaproterenol: beta 2 selective with some beta 1 activity, less selective than albuterol or terbutaline
• Bitolterol: hydrolyzed by esterase in the lung to colterol, or terbutylnorepinephrine, selective beta 2

Long Acting Beta Agonists (Salmeterol, formoterol, indacaterol, and aformoterol)

• Salmeterol is more selective for beta2 receptors than albuterol and has minor beta1 activity.
o 12 hour half-life
o Formoterol: 200-fold greater agonist activity at B2 than albuterol and has minor B1 activity
o Aformoterol (R,R)-enantiomer of formoterol, twice as potent as formoterol
o Indacaterol: 24 fold greater B2 activity than B1
o Salmeterol and formoterol exert long-lasting broncho protection against allergen, exercise, histamine, and
methacholine caused bronchospasm

,Pharmacokinetics
• Contraindications: Cardiac arrhythmias (tachycardia or heart block caused by digitalis intoxication,
angina, narrow-angle glaucoma, organic brain damage (epi only), and shock during general anesthesia with
halogenated agents
• Monitor closely: HTN, ischemic heart disease, coronary insufficiency, CGH, and Hx of stroke and/or
cardiac arrhythmias
• Diabetics: potential drug-induced hyperglycemia, insulin dose may need increased
• Hyperthyroidism: ADRs are more likely to occur with use of bronchodilators
• Digoxin: require close monitoring, albuterol increases the volume of distribution of dig and can cause
decreased dig blood levels
• Pheochromocytoma: avoid, severe HTN may occur
• Older adults: Lower doses r/t increased sympathomimetic sensitivity
• Black Box warning for LABAs: The risks of salmeterol (Serevent) and formoterol (Foradil) outweighed
the benefits and should not be used singly in asthma for all ages
o Two-fold increase in catastrophic events (asthma-related intubations and death)
o The use of LABAs is contraindicated without the use of an asthma controller medication such as an
inhaled corticosteroid
o Only use long-term in patients who asthma cannot be adequately controlled on asthma controller
medications
o Use for the shortest duration of time required to achieve control, then maintain on an asthma
controller medication
o Pediatric and adolescent patient who require addition of a LABA to an inhaled corticosteroid should
be a combination product containing both an inhaled ICS and a LABA, to ensure compliance with
both medications
• Terbutaline pregnancy category B (prevent contractions) (others category C)
• Albuterol safe for all age children
• Metaproterenol can be used in young children
• Levalbuterol, as young as 2 (drug insert says 6)
• Salmeterol should not be used in children less than age 4 years and never singly.
• Formoterol age 5 and older
• Indacaterol and aformoterol are used for COPD, not for use in children or adolescents

Drug and Food Interactions
o Many drug interactions
o Digitalis glycosides: increased risk of dysrhythmia
o Beta adrenergic blocking agents (Beta Blockers): direct competition for beta sites resulting in mutual
inhibition of therapeutic effects
o Including beta blocker eye drops
o Tricyclic antidepressants and MAOIs potentiate effects of beta agonist on vascular system

ADRs
o Usually transient
o Stopping the med is not usually needed, reduce dose then slowly increase
o Supraventricular and ventricular ectopic beats have occurred
o Tachycardia and palpitations
o Some central nervous system (CNS) excitation effects
o Tremors, dizziness, shakiness, nervousness, and restlessness
o Headaches, rarely insomnia, post inhalation cough
o Salmeterol has an increased risk of exacerbation of severe asthma symptoms if the patient is
deteriorating
o Overuse can lead to seizures, hypokalemia, anginal pain and HTN

, o Stimulant like effects
o GI upset, take po meds with food

Clinical Use and Dosing
Bronchospasm
• Bronchodilators are used primarily in the treatment of bronchospasm associated with asthma, bronchitis
(acute or chronic), and chronic obstructive pulmonary disease (COPD)
o Albuterol
 MDI dose children over 4 and adults is 2 puffs every 4 to 6 hours
o Nebulizer dose children over age 12 and adults is 2.5 mg/dose
 For younger children over 15 kg, dose is 0.1 to 0.15 mg/kg/dose
o Dose may be repeated once after 5 to 10 minutes, up to 2 times, three doses total during
exacerbations
o Oral dose in adults is 2 to 4 mg 3 or 4 times a day
 For children 6 to 12, 2 mg albuterol 3 to 4 times a day (PO form rarely used in
children)
 Oral syrup: children under age 6, 0.1 mg/kg 3 times a day (rarely used)
o May combine with ipratropium
o Aformoterol (Brovana): nebulizer 15 mcg/ by inhalation BID (not approved for use in children)
o Indacaterol (Arcapta Neohaler): powder via a Neohaler device
 adults with COPD, one capsule one daily with a Neohaler device
o Levalbuterol (Xopenex): inhalation solution (nebulizer) in adolescents over age 12 and adults is 0.63
mg TID (every 6 to 8 hours)
 Children: 6 to 11: 0.31 mg TID, do not exceed 0.63 mg TID
 Children 4 and younger: 0.31 to 1.25 mg every 4 to 6 hours
 Inhaler: one to two puffs repeated every 4 to 6 hours
o Metaproterenol (Alupent): MDI, inhalation solution, and syrup forms
o Terbutaline: MDI (Brethaire), PO tablets (Brethine), or parenteral form for SC injection
o Pirbuterol: only available as MDI (Maxair Autohaler)
o Bitolterol (Tornalate): MDI: acute bronchospasm two puffs 1 to 3 minutes apart
o Salmeterol (Serevent DISKUS): 1 puff BID
o Do not use alone for persistent asthma, combine with an inhaled corticosteroid
o Packaged with Fluticasone (Advair DISKUS) differing doses
o Formoterol: 12 mcg, single use dry powder capsule
o Ipratropium: inhaled anticholinergic, may be used in combination with albuterol to treat asthma
exacerbation in the ER
 Bronchodilator of choice3 in patients taking beta blockers or who do not tolerate beta 2
agonists

Exercise-induced bronchospasm (EIB)
o Albuterol or other SABA and salmeterol
o Albuterol MDI: 2 puffs 15 minutes before exercise, lasts 2-3 hours
o Salmeterol: 2 puffs 30 to 60 minutes before exercise, duration 10 to 12 hours
o Cromolyn or nedocromil may be used before exercise, not as effective
o Leukotriene modifiers taken daily may decrease EIB symptoms in 50% of patients, but patient
will still need to use albuterol before exercise

Xanthine derivatives
o Methylxanthines have declined in importance in the Tx of asthma, but some patients may still benefit from
the use of theophylline
o Theophylline and Caffeine

, o Bronchodilator

Pharmacodynamics
o Bronchial smooth muscle relaxation
o CNS stimulants
o CV effects
o Increased gastric acid production
o Stimulate skeletal muscle
o Increased renal blood flow and GFR
o Work directly by an unknown mechanism: mediated by selective inhibition of specific phosphodiesterase
o Increased production of cAMP=bronchial smooth muscle and pulmonary vessel
relaxation
o Theophylline and caffeine: powerful CNS stimulants (insomnia and excitability)
o Theophylline has a greater effect on the cardiovascular system
o Theophylline directly stimulates the myocardium and increases myocardial contractility and HR
o Relaxes vascular smooth muscle, dilates the coronary, pulmonary, and systemic blood vessels
o Both theophylline and caffeine: increase gastric acid production (may cause NV)
o Stimulate skeletal muscle: tremors
o Theophylline: Acts directly on the renal tubules to cause increased sodium and chloride excretion
o Both cause diuresis r/t action on the kidneys (increased blood flow to kidneys)

Pharmacotherapeutics

o Contraindications to theophylline: hypersensitivity to xanthine, PUD, and underlying seizure disorder
o Contraindications to caffeine: hypersensitivity to caffeine or use of caffeine sodium benzoate formulation
in neonates
o Use Caution: HTN, ischemic heart disease, coronary insufficiency, CHF, or Hx of stroke and cardiac
arrhythmias r/t effects on CV system
o Toxicity: levels above 25 mcg/mL
 May occur if clearance is decreased (hepatic impairment, chronic lung disease, cardiac failure,
patients older than 55, and infants under 1)
o Theophylline: Pregnancy Category C, crosses placenta, newborns may have therapeutic serum levels if
maternal levels are high-normal range (tachycardia, irritability, and vomiting)
o May be used in children: infants younger than 1 have decreased theophylline clearance and closely monitor
levels should be a range of 5 to 10 mcg/mL
o Caffeine citrate is used to treat apnea of prematurity
o Pregnancy Category C

Theophylline: Drug and Food Interactions

o Many drug interactions due to metabolism via CYP 450 isoenzyme CYP1A2, CYP2E1, and CYP 3A3/4
o Increase serum theophylline: allopurinol, VVs, CCBs, cimetidine, cipro, oral contraceptives,
corticosteroids, disulfiram, ephedrine, flu vaccine, interferon, macrolides, quinolones, THs,
carbamazepine, IZD, loop diuretics
o Decrease serum theophylline: aminoglutethimide, barbiturates, charcoal, hydantoins, ketoconazole,
rifampin, smoking, sulfinpyrazone, beta agonists, carbamazepine, isoniazid, loop diuretics, lansoprazole,
primidone, ritonavir
o Lithium: theophylline may increase renal clearance of lithium=reduced levels
o Smoking tobacco increases theophylline clearance (may take months to 2 years to normalize theophylline
clearance after quitting)
o Benzodiazepines are antagonized by theophylline

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Welch1. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$18.57. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

82871 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Other

NR566 Week 2 Study Outline_ Chapter 17: Drugs Affecting the Respiratory System

Document information

Subjects

Written for

Seller

Reviews received

Content preview